Australia markets closed

Acurx Pharmaceuticals, Inc. (ACXP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.0700+0.0500 (+2.48%)
At close: 04:00PM EDT
2.0600 -0.01 (-0.48%)
After hours: 04:00PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts1111
Avg. Estimate-0.24-0.2-0.97-2.3
Low estimate-0.24-0.2-0.97-2.3
High estimate-0.24-0.2-0.97-2.3
Year ago EPS-0.25-0.28-1.15-0.97
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts1122
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.29-0.27-0.27-0.26
Actual EPS-0.25-0.28-0.24-0.37
Difference0.04-0.010.03-0.11
Surprise %13.80%-3.70%11.10%-42.30%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.24-0.2-0.97-2.3
7 days ago-0.24-0.2-0.97-2.3
30 days ago-0.24-0.2-0.97-2.3
60 days ago-0.23-0.2-0.83-1.48
90 days ago-0.23-0.2-0.83-1.48
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesACXPIndustrySector(s)S&P 500
Current qtr.4.00%N/AN/AN/A
Next qtr.28.60%N/AN/AN/A
Current year15.70%N/AN/AN/A
Next year-137.10%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A